Multicomponent Ear Tissue Scaffold for Auricular Reconstruction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ear implant devices, such as those made from high density porous polyethylene, face challenges including limited customization for patient-specific anatomy, high rates of fracture, exposure, and infection, and lack the ability to support tissue growth or cell ingrowth, making them unsuitable for a wide range of patients, especially children and adults with congenital deformities.
Innovation Solution
A multicomponent ear implant assembly comprising two tissue scaffold components made from biocompatible polymeric materials with open pores, designed to support cell growth and tissue ingrowth, which can be customized using image-based design and 3D printing techniques, allowing for structural stability, expansion, and integration with the patient's anatomy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If rigid synthetic polymeric material (high density porous polyethylene) is used for ear implant, then structural stability is improved, but fracture rate and extrusion rate increase
Solution Approach 1:
The patent changes the material parameters from rigid synthetic polyethylene to flexible biocompatible polymers (such as silicone elastomers or polyurethanes) with controlled elasticity and porosity. This parameter change maintains structural stability while reducing fracture and extrusion rates by allowing the implant to flex with surrounding tissues rather than resisting movement rigidly.
Solution Approach 2:
The patent employs composite material structures combining flexible polymer matrices with porous architectures. This composite approach provides both the structural stability needed for implant support and the flexibility required to prevent fracture and extrusion, resolving the contradiction between rigidity and reliability.
2Object-affected harmful factors
If commercially available synthetic implant is used, then avoidance of donor site morbidity is achieved, but customization for patient-specific anatomy is limited
Solution Approach 1:
The patent divides the implant into modular components that can be selectively assembled to match patient-specific anatomy. This segmentation allows customization of implant size, shape, and configuration without requiring donor site harvesting, as each module can be independently selected and combined.
Solution Approach 2:
The patent utilizes adjustable geometric parameters and configurable structural features in the implant design that can be modified to match various anatomical configurations. This allows the same basic implant design to be adapted to different patients without requiring custom fabrication or donor tissue.
3Device complexity
If single available ear implant device is used, then simplicity of implant selection is maintained, but capacity for growth and tissue ingrowth is lost
Solution Approach 1:
The patent incorporates dynamic features into the implant design, including expandable structures and adjustable components that can grow or adapt over time. The implant can be initially sized for pediatric patients and then expanded or adjusted as the patient grows, maintaining simplicity in initial selection while providing growth capacity through programmable or mechanically adjustable features.
4Ease of manufacture
If porous polyethylene material is used, then ease of manufacture is improved, but rates of exposure, extrusion, and infection increase
Solution Approach 1:
The patent employs porous polymer structures with controlled pore sizes and distributions that facilitate tissue ingrowth while maintaining manufacturing feasibility. The porosity is optimized to allow cellular infiltration and vascularization, reducing exposure and infection rates, while the polymer matrix remains compatible with standard manufacturing processes like injection molding or 3D printing.
Solution Approach 2:
The patent combines porous polymer structures with biocompatible surface coatings or integrated antimicrobial features. This composite approach maintains the ease of manufacturing porous structures while adding protective properties that reduce infection and exposure rates through material composition rather than complex processing.
Data Source
AI summary
Ear implants for auricular tissue reconstruction in a patient are provided. The ear implant may be a tissue scaffold multicomponent assembly for reconstruction of auricular tissue. Thus, the assembly may include both a first and a second tissue scaffold component. Each comprises a biocompatible polymeric material having a plurality of open pores configured to support cell growth. The first tissue scaffold component defines a central void region and at least a portion of an outer ear framework of the patient after implantation. The second tissue scaffold component defines a base portion. After implantation into the patient, the second tissue scaffold component seats within the central void region of the first tissue scaffold component, so that the second tissue scaffold component is secured to the first tissue scaffold component. Methods for reconstructing auricular tissue in a patient using such ear implant tissue scaffolds are also provided.